Skip to main navigation
Skip to content
Skip to content
PDL Logo Blue Green
  • About PDL
    • Leadership
  • Equity Investments
    • Noden
    • Noden’s Products
    • Lensar
    • LENSAR Product
  • Alternative Financings
    • Portfolio of Assets
    • On-Going Transactions
    • Concluded Transactions
  • Investor Relations
  • News
  • Contact
  • About PDL
    • Management
  • Equity Investments
    • Noden
    • Noden’s Products
    • Lensar
    • LENSAR Product
  • Alternative Financings
    • Portfolio of Assets
    • On-Going Transactions
    • Concluded Transactions
  • Investor Relations
  • News
  • Contact

Press Releases

PDL  > Investor Relations > Press Releases

Press Releases

  • Summary TogglePDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance
    Conference Call Today at 4:30 p.m. Eastern Time -
    Mar 2, 2010
    PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance 26.9 KB
  • Summary TogglePDL BioPharma to Announce Fourth Quarter and Full Year 2009 Financial Results and Hold Conference Call on March 2, 2010
    PDL BioPharma to Announce Fourth Quarter and Full Year 2009 Financial Results and Hold Conference Call on March 2, 2010 INCLINE VILLAGE, Nev., Feb 22, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold a conference call and webcast on
    Feb 22, 2010
    PDL BioPharma to Announce Fourth Quarter and Full Year 2009 Financial Results and Hold Conference Call on March 2, 2010 8.4 KB
  • Summary TogglePDL BioPharma to Present at the 12th Annual BIO CEO & Investor Conference on February 8, 2010
    PDL BioPharma to Present at the 12th Annual BIO CEO & Investor Conference on February 8, 2010 INCLINE VILLAGE, Nev., Feb 02, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will
    Feb 2, 2010
    PDL BioPharma to Present at the 12th Annual BIO CEO & Investor Conference on February 8, 2010 8.5 KB
  • Summary TogglePDL BioPharma Announces Two $0.50 Dividends in 2010
    Distribution Dates of April 1 and October 1, 2010
    Jan 28, 2010
    PDL BioPharma Announces Two $0.50 Dividends in 2010 8.7 KB
  • Summary TogglePDL BioPharma Provides Federal Income Tax Information Regarding 2009 Dividend Payments
    PDL BioPharma Provides Federal Income Tax Information Regarding 2009 Dividend Payments INCLINE VILLAGE, Nev., Jan 21, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (Nasdaq: PDLI) today announced the allocation between dividend income and return of capital for federal income tax purposes for
    Jan 21, 2010
    PDL BioPharma Provides Federal Income Tax Information Regarding 2009 Dividend Payments 8.6 KB

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 20
  • Page 21
  • Page 22
  • Current page 23

    Investor Relations

    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Tax Information
    • SEC Filings
    • Stock Information
    • Contact Us

    Current Alternative Investments

    image

    Learn More

     

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • RSS
    • Print
    • Share
    • Search
    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS

PDL Logo White Fill

  • Terms of Use
  • Sitemap
© Copyright 2019 PDL BioPHARMA. All Rights Reserved.